Adenocarcinoma em pouch gástrico após 10 anos de bypass gástrico em Y-de-Roux: um relato de caso
Article Sidebar
Main Article Content
Abstract
A obesidade é uma doença de alta e crescente prevalência em todo o mundo. O tratamento cirúrgico através do bypass gástrico em Y-de-Roux (BGYR) é eficiente e duradouro no tratamento do excesso de peso e suas comorbidades associadas, auxiliando inclusive, na redução de incidência de neoplasias. Apesar disso, há raros casos na literatura de pacientes pós-cirurgia bariátrica com câncer esôfago-gástrico. A definição dos mecanismos associados a essas duas patologias é incerta, sendo recentemente um objeto de estudo. Neste artigo, realizamos uma revisão de literatura a respeito deste assunto e descrevemos o caso de uma paciente submetida a BGYR que, após 10 anos da cirurgia, desenvolveu adenocarcinoma no pouch gástrico.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
World Health Organization. Overweight and obesity [Internet] Geneva: World Health Organization; 2024. [Disponível em: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight].
Eisenberg D, Shikora SA, Aarts E, Aminian A, Angrisani L, Cohen RV, et al. 2022 American society for metabolic and bariatric surgery (ASMBS) and international federation for the surgery of obesity and metabolic disorders (IFSO): indications for metabolic and bariatric surgery. Surg Obes Relat Dis. (2022) 18(12):1345–56. doi: 10.1016/j.soard.2022.08.013
Angrisani L, Santonicola A, Iovino P, et al. Bariatric surgery and endoluminal procedures: IFSO worldwide survey 2014. Obes Surg.2017;27(9):2279–89.
Aminian A, Wilson R, Al-Kurd A, et al. Association of bariatric surgery with cancer risk and mortality in adults with obesity. JAMA. 2022;327(24):2423–33. doi:10.1001/jama.2022.9009
Chen ZW, Jin T, Liang PP, Li ZD, He FJ, Chen ZH, Song XH, Zhu YF, Hu JK, Yang K. Incidence of cancer for patients after bariatric surgery: evidence from 33 cohort studies. Surg Obes Relat Dis. 2023 Nov 27:S1550-7289(23)00801-8. doi: 10.1016/j.soard.2023.11.010.
Castagneto-Gissey L, Casella-Mariolo J, Casella G, Mingrone G. Obesity surgery and cancer: what are the unanswered questions? Front Endocrinol (Lausanne). (2020) 11:213. doi: 10.3389/fendo.2020.00213
Gastric cancer: epidemiology, risk factors, classification, genomic characteristics and treatment strategies. Machlowska J, Baj J, Sitarz M, Maciejewski R, Sitarz R. Int J Mol Sci. 2020;21:4012
Epidemiology of gastric cancer: global trends, risk factors and prevention. Rawla P, Barsouk A. Prz Gastroenterol. 2019;14:26–38.
MacDonald WC, Owen DA. Gastric carcinoma after surgical treatment of peptic ulcer: an analysis of morphologic features and a comparison with cancer in the nonoperated stomach. Cancer. 2001 May 1;91(9):1732-8. doi: 10.1002/1097-0142(20010501)91:9<1732::aid-cncr1191>3.0.co;2-x
Chemaly R, Diab S, Khazen G, Al-Hajj G. Gastroesophageal Cancer After Gastric Bypass Surgeries: a Systematic Review and Meta-analysis. Obes Surg. 2022 Apr;32(4):1300-1311. doi: 10.1007/s11695-022-05921-4
Doukas SG, Doukas PG, Vageli DP, Broder A. Gastric cancer after Bariatric Bypass Surgery. Do they relate? (A Systematic Review). Obes Surg. 2023 Jun;33(6):1876-1888. doi: 10.1007/s11695-023-06567-6
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F: Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021, 71:209-249. doi: 10.3322/caac.21660
Brito H, Santos AC, Preto J, Carvalho D, Freitas P; CRIO Group. Obesity and Cancer: the Profile of a Population who Un-derwent Bariatric Surgery. Obes Surg. 2021 Nov;31(11):4682-4691. doi: 10.1007/s11695-021-05626-0
MacDonald WC, Owen DA. Gastric carcinoma after surgical treatment of peptic ulcer: an analysis of morphologic features and a comparison with cancer in the nonoperated stomach. Cancer. 2001 May 1;91(9):1732-8. doi: 10.1002/1097-0142(20010501)91:9<1732::aid-cncr1191>3.0.co;2-x
Li JV, Reshat R, Wu Q, et al. Experimental bariatric surgery in rats generates a cytotoxic chemical environment in the gut contents. Front Microbiol. 2011;2:183. https://doi.org/10.3389/fmicb.2011.00183.
Lazzati A, Poghosyan T, Touati M, Collet D, Gronnier C. Risk of Esophageal and Gastric Cancer After Bariatric Surgery. JAMA Surg. 2023;158(3):264–271. doi:10.1001/jamasurg.2022.6998
Ribeiro MC, Lopes LR, Coelho Neto Jde S, Tercioti V Jr, Andreollo NA. Gastric adenocarcinoma after gastric bypass for morbid obesity: a case report and review of the literature. Case Rep Med. 2013;2013:609727. doi: 10.1155/2013/609727
Scozzari G, Trapani R, Toppino M, Morino M. Esophagogastric cancer after bariatric surgery: systematic review of the liter-ature. Surg Obes Relat Dis. 2013;9(1):133–42. doi 10.1016/j. Soard.2012.10.002.
Inoue H, Rubino F, Shimada Y, et al. Risk of Gastric Cancer After Roux-en-Y Gastric Bypass. Arch Surg. 2007;142(10):947–953. doi:10.1001/archsurg.142.10.947
Brown, W. A., Johari Halim Shah, Y., Balalis, G., Bashir, A., Ramos, A., Kow, L., Herrera, M., Shikora, S., Campos, G. M., Himpens, J., & Higa, K. (2020). IFSO Position Statement on the Role of Esophago-Gastro-Duodenal Endoscopy Prior to and after Bariatric and Metabolic Surgery Procedures. Obesity Surgery, 30(8), 3135–3153. doi 10.1007/s11695-020-04720-z
van de Vrande S, Himpens J, Leman G. Adenocarcinoma of the gastric pouch after Roux-en-Y gastric bypass: a new technique for en bloc resection and reconstruction. Surg Obes Relat Dis. 2017 Oct;13(10):1793-1795. doi: 10.1016/j.soard.2017.07.006.